Non-Hemostatic Roles of von Willebrand Factor in Gastrointestinal Angiodysplasia: Mechanisms and Therapeutic Implications
Alan (mail bueno) Nurden shared a post on LinkedIn:
“This is an up-to-date and well-written review highlighting the non-hemostatic role of von Willebrand factor in angiodysplasia of the gastro-intestinal tract; a rare condition that complicates life for patients with von Willebrand disease. The role of VWF multimers in binding angiopoietin-2 and growth factors such as vascular endothelial growth factor and presenting them to endothelial cells via avβ3 is emphasized. The authors discuss the signaling pathways that cause increased angiogenesis in vascular deformation syndromes and how these represent possible novel therapeutic targets. The authors are to be congratulated for an informative and highly readable review. It will be interesting to see how this relates to gastrointestinal bleeding in patients with Glanzmann thrombasthenia where angiodysplasia linked to gastrointestinal bleeding is also seen, often for elderly patients, greatly interfering with their quality of life.”
Read the full paper here.
Title: von Willebrand disease and angiodysplasia: a wider view of pathogenesis in pursuit of therapy
Authors: Christina Crossette-Thambiah, Anna M. Randi, Michael Laffan

Find similar posts on Hemostasis Today.
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM
-
Aug 26, 2026, 13:59David McIntosh: Immunoglobulin Stewardship in the Face of Rising Demand
-
Aug 26, 2026, 13:54Giuseppe Biondi Zoccai: Congratulations to the Next Editor-in-Chief of the EHJ
-
Aug 26, 2026, 13:25Omar Adwan: Abnormal Nuclear Morphology of Neutrophil
-
Aug 26, 2026, 13:05Preventing Thrombosis with WTDay26
-
Aug 26, 2026, 10:09Gemma Figtree: How Well Do We Predict Heart Attack Risk in Women?
-
Aug 26, 2026, 10:06Understanding and Managing Fatigue in ITP – ITP Support Association
-
Aug 26, 2026, 10:04Abdul Muqtadir Abbasi: When a High INR Hides a Thrombotic Cancer
-
Aug 26, 2026, 09:42Mohammed Alo: What’s Wrong With the New Blood Pressure Guidelines?